Showing results (241-250 of 261) with videos related to

Sort By:
Pageof 27
Journal of the American College of Cardiology|December 15, 2015
Building Sustainable Capacity for Cardiovascular Care at a Public Hospital in Western KenyaCynthia A Binanay, Constantine O Akwanalo, Wilson Aruasa, et al.
JAMA Cardiology|December 11, 2024
Pitavastatin, Procollagen Pathways, and Plaque Stabilization in Patients With HIV: A Secondary Analysis of the REPRIEVE Randomized Clinical TrialMárton Kolossváry, Samuel R Schnittman, Markella V Zanni, et al.
Open Forum Infectious Diseases|October 22, 2024
Effects of Pitavastatin on COVID-19 Incidence and Seriousness Among a Global Cohort of People With HIVMarkella V Zanni, Triin Umbleja, Carl J Fichtenbaum, et al.
AIDS (London, England)|June 18, 2025
No evidence of a detrimental effect of pitavastatin on neurocognitive function among people with HIVKristine M Erlandson, Ashley McKhann, Douglas W Kitch, et al.
The Lancet. HIV|April 3, 2025
Statin effects on the incidence of major non-cardiovascular disease events among a global cohort of people with HIV: a randomised controlled trialMarissa R Diggs, Triin Umbleja, Sara McCallum, et al.
AIDS (London, England)|July 24, 2025
No evidence of pitavastatin effect on muscle area or density among people with HIVKristine M Erlandson, Triin Umbleja, Heather J Ribaudo, et al.
The Lancet. HIV|April 5, 2026
Pitavastatin effects on lipids in relation to major adverse cardiovascular events: a REPRIEVE secondary analysisTriin Umbleja, Mohammad U Zafar, Sara McCallum, et al.
JACC. Advances|August 21, 2025
Frailty, Pitavastatin, and Major Adverse Cardiovascular Events Among People With HIVKristine M Erlandson, Ariela R Orkaby, Triin Umbleja, et al.
The Journal of Infectious Diseases|July 10, 2020
Patterns of Antiretroviral Therapy Use and Immunologic Profiles at Enrollment in the REPRIEVE TrialCarl J Fichtenbaum, Heather J Ribaudo, Jorge Leon-Cruz, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 14, 2022
Sex Differences in Subclinical Atherosclerosis and Systemic Immune Activation/Inflammation Among People With Human Immunodeficiency Virus in the United StatesMarkella V Zanni, Borek Foldyna, Sara McCallum, et al.
Pageof 27